Back to search
FDAFDA · Food and drugs·Recall number Z-2024-2012

Respironics Trilogy 100, 200, and 202 Ventilators The Respironics Trilogy systems provides continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. Trilogy 100 is intended for pediatric through adult patients weighing at least 5 kg (11 lbs.). The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys, and may be used for both invasive and non-invasive ventilation. They are not intended to be used as a transport ventilator.

Published August 1, 2012 · Recall initiated: April 27, 2012

Summary

FDA records medical device Class I recall Z-2024-2012, published August 1, 2012 and initiated April 27, 2012. Recalling firm: Respironics, Inc.; Status: Terminated; Reported quantity: 173; Lot: Model/Catalog Numbers: 1032800, 1040004, 1040007, 1054096, 1054260, CA1032800, R1040004, R1054655, and 1045151. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Respironics, Inc.
Distributor
Worldwide Distribution - USA including AZ, CA, IL, IN, LA, MI, MN, MO, NJ, NY, NC, PA, SC, TN, TX, and WI and the countries of Canada, Denmark, Estonia, Finland, France, Great Britian, India, Italy, Japan, Korea, Saudi Arabia, and Spain.
Lot
Model/Catalog Numbers: 1032800, 1040004, 1040007, 1054096, 1054260, CA1032800, R1040004, R1054655, and 1045151.
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Respironics Trilogy 100, 200, and 202 Ventilators The Respironics Trilogy systems provides continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. Trilogy 100 is intended for pediatric through adult patients weighing at least 5 kg (11 lbs.). The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys, and may be used for both invasive and non-invasive ventilation. They are not intended to be used as a transport ventilator. recalled?

Yes. FDA published recall Z-2024-2012 on August 1, 2012. Reported hazard: The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone